DE69915849D1 - Verwendung von gnrh analogen zur behandlung von schizophrenie - Google Patents

Verwendung von gnrh analogen zur behandlung von schizophrenie

Info

Publication number
DE69915849D1
DE69915849D1 DE69915849T DE69915849T DE69915849D1 DE 69915849 D1 DE69915849 D1 DE 69915849D1 DE 69915849 T DE69915849 T DE 69915849T DE 69915849 T DE69915849 T DE 69915849T DE 69915849 D1 DE69915849 D1 DE 69915849D1
Authority
DE
Germany
Prior art keywords
treating schizophrenia
gnrh analogs
schizophrenia
gnrh
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69915849T
Other languages
English (en)
Inventor
Tomas Eriksson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAEKARTJAENSTER I VAESTSVERIGE
Original Assignee
LAEKARTJAENSTER I VAESTSVERIGE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LAEKARTJAENSTER I VAESTSVERIGE filed Critical LAEKARTJAENSTER I VAESTSVERIGE
Application granted granted Critical
Publication of DE69915849D1 publication Critical patent/DE69915849D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Soundproofing, Sound Blocking, And Sound Damping (AREA)
  • Networks Using Active Elements (AREA)
DE69915849T 1998-08-26 1999-08-25 Verwendung von gnrh analogen zur behandlung von schizophrenie Expired - Lifetime DE69915849D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802836A SE514606C2 (sv) 1998-08-26 1998-08-26 Läkemedel innehållande GnRH-analoger för behandling av schizofreni
PCT/SE1999/001441 WO2000012115A1 (en) 1998-08-26 1999-08-25 Use of composition in the treatment of schizophrenia

Publications (1)

Publication Number Publication Date
DE69915849D1 true DE69915849D1 (de) 2004-04-29

Family

ID=20412345

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69915849T Expired - Lifetime DE69915849D1 (de) 1998-08-26 1999-08-25 Verwendung von gnrh analogen zur behandlung von schizophrenie

Country Status (7)

Country Link
US (1) US6468973B1 (de)
EP (1) EP1115415B1 (de)
AT (1) ATE262343T1 (de)
AU (1) AU5890499A (de)
DE (1) DE69915849D1 (de)
SE (1) SE514606C2 (de)
WO (1) WO2000012115A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE511005C2 (sv) * 1998-07-07 1999-07-19 Laekartjaenster I Vaestsverige Användning av komposition omfattande minst ett ämne inom gruppen GnRH-analoger för framställning av ett läkemedel för behandling av tvångstanke-tvångshandlingssjukdom
IL147138A0 (en) 2001-12-17 2002-08-14 Yeda Res & Dev Methods of and pharmaceutical compositions for modulating cell adhesion, migration and extravasation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474813A (en) * 1980-10-24 1984-10-02 Schering Corporation Pharmaceutical preparations comprising flutamide
DE3726324A1 (de) * 1987-08-07 1989-02-16 Hoechst Ag Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute
FR2661180B1 (fr) * 1990-04-23 1995-04-28 Inst Nat Sante Rech Med (hydroxyproline 9) lhrh, son procede d'obtention et application comme medicament.
RU2091390C1 (ru) * 1995-02-28 1997-09-27 Научно-исследовательский институт фармакологии РАН Замещенные пролилтирозины, обладающие психотропной активностью

Also Published As

Publication number Publication date
US6468973B1 (en) 2002-10-22
ATE262343T1 (de) 2004-04-15
SE514606C2 (sv) 2001-03-19
SE9802836L (sv) 2000-02-27
AU5890499A (en) 2000-03-21
EP1115415A1 (de) 2001-07-18
WO2000012115A1 (en) 2000-03-09
SE9802836D0 (sv) 1998-08-26
EP1115415B1 (de) 2004-03-24

Similar Documents

Publication Publication Date Title
ATE324908T1 (de) Verwendung von anti-rubeola antkörpern zur behandlung von symptomen von erkrankungen des zentralen nervensystems
DE60031396D1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
MXPA03010232A (es) Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central.
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE232874T1 (de) Prostaglandin-konjugate zur behandlung von knochenkrankheiten
ATE389395T1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
ATE428413T1 (de) Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen
BR0215395A (pt) Compostos; processo para a preparação de um composto; composição farmacêutica; e método para o tratamento e/ou profilaxia de doenças que estão relacionadas com o nìvel de glicose no sangue
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
ATE271861T1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
BR0316523A (pt) Composto, composição farmacêutica e método para tratar ou prevenir câncer em um paciente
DE69924146D1 (de) Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen
ATE372114T1 (de) Verfahren zur erhöhung des testosteronspiegels
ATE402694T1 (de) Verwendung von 1-phenyl-3-dimethylamino-propan- verbindungen zur therapie der harninkontinenz
DE60108130D1 (de) Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten
DE69915849D1 (de) Verwendung von gnrh analogen zur behandlung von schizophrenie
DE50108711D1 (de) Verwendung von substituierten 6-dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur therapie der harninkontinenz
ATE304862T1 (de) Verwendung einer zusammensetzung enthaltend zumindest ein gnrh-analoges zur behandlung von zwangsneurotischen erkrankungen
HUP0100105A2 (hu) TNF-antagonisták alkalmazása szeptikus betegségek kezelésére szolgáló gyógyszerként
ATE267194T1 (de) Medikamente geeignet zur behandlung von proliferativen erkrankungen
DE60004473D1 (de) Verwendung von gaba-b rezeptor liganden zur herstellungen von medikamenten zur behandlung von neurodegenerativen erkrankungen
EA200600115A1 (ru) Производные 2-аминобензойной кислоты
DE60128084D1 (de) Verwendung von inaktives cln2 proenzym zur behandlung von lincl
DE69924385D1 (de) Verwendung von angiotensin zur behandlung von krebsmetastasierung

Legal Events

Date Code Title Description
8332 No legal effect for de